Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2009
Molecular imaging of hypoxia with radiolabelled agentsGilles Mees, Rudi Dierckx, Christel Vangestel, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Forcing cancer cells to commit suicideChristel Vangestel, Christophe Van de Wiele, Gilles Mees, et al.
Current Pharmaceutical Design|September 13, 2013
Radiolabelled probes targeting tumor hypoxia for personalized medicineGilles Mees, Mike Sathekge, Alex Maes, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 1, 2012
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerationsKoen Mertens, Gilles Mees, Bieke Lambert, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2015
[18F]FDG PET/CT for the assessment of the volume of the spleenPeter Smeets, Gilles Mees, Hamphrey Ham, et al.
Histology and Histopathology|July 14, 2011
Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinomaPhilippe Deron, Hubert Vermeersch, Gilles Mees, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancerGilles Mees, Christel Vangestel, Rudi Dierckx, et al.
Molecular Imaging|January 26, 2013
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?Gilles Mees, Rudi Dierckx, Christel Vangestel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2012
SIRT of liver metastases: physiological and pathophysiological considerationsChristophe Van de Wiele, Alex Maes, Eddy Brugman, et al.
Molecular Imaging|April 4, 2012
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft modelChristel Vangestel, Christophe Van de Wiele, Gilles Mees, et al.
Pageof 2